Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone
…, AR Hermus, HA Ross, WC Buijs… - Journal of Nuclear …, 2004 - Soc Nuclear Med
A single, low dose of recombinant human thyroid-stimulating hormone (rhTSH) doubles 24-h
RAIU and causes a more homogeneous distribution of radioiodine on thyroid scintigrams of …
RAIU and causes a more homogeneous distribution of radioiodine on thyroid scintigrams of …
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study
C Buijs, CH Mom, PHB Willemse… - Breast cancer research …, 2009 - Springer
Purpose Breast cancer patients with treatment-induced menopause experience frequent
and severe hot flashes (HF). We compared venlafaxine and clonidine for the treatment of HF …
and severe hot flashes (HF). We compared venlafaxine and clonidine for the treatment of HF …
[PDF][PDF] 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation
…, P Laverman, PJM Kok, WCAM Buijs… - Journal of Nuclear …, 2000 - Soc Nuclear Med
Polyethyleneglycol (PEG) liposomes have been shown to be excellent vehicles for scintigraphic
imaging of infection and inflammation in various experimental models. In this article we …
imaging of infection and inflammation in various experimental models. In this article we …
[PDF][PDF] Absolute organ activity estimated by five different methods of background correction
WCAM Buijs, JA Siegel, OC Boerman… - Journal of Nuclear …, 1998 - Soc Nuclear Med
+ 39%. Conclusion: Even though quantitative SPECT is the most rigorous method for activity
quantification in conditions of low organ-to-background activity concentration ratio, planar …
quantification in conditions of low organ-to-background activity concentration ratio, planar …
Targeting of Metastatic Renal Cell Carcinoma with the Chimeric Monoclonal Antibody G250 Labeled with 131I or 111In: An Intrapatient Comparison
…, WCAM Buijs, E Oosterwijk, OC Boerman, C Mala… - Clinical cancer …, 2003 - AACR
Purpose: There is increasing evidence that the chimeric monoclonal antibody G250 (cG250)
can be internalized by G250 antigen-expressing renal cell carcinoma (RCC) cells. Thus, …
can be internalized by G250 antigen-expressing renal cell carcinoma (RCC) cells. Thus, …
Lack of Efficacy of Two Consecutive Treatments of Radioimmunotherapy With 131I-cG250 in Patients With Metastasized Clear Cell Renal Cell Carcinoma
…, WJM van den Broek, WCAM Buijs, C Mala… - Journal of clinical …, 2005 - ascopubs.org
Purpose A previous activity dose-escalation study using 131 I-labeled chimeric monoclonal
antibody cG250 in patients with progressive metastatic renal cell carcinoma (RCC) resulted …
antibody cG250 in patients with progressive metastatic renal cell carcinoma (RCC) resulted …
[PDF][PDF] Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters
DAKC Huysmans, WCAM Buijs… - Journal of Nuclear …, 1996 - Soc Nuclear Med
1311). An iodine biokinetic model and the MIRD methodology were used to estimate
absorbed doses in organs. Cancer risks were calculated using ICRP Publication 60. Results: …
absorbed doses in organs. Cancer risks were calculated using ICRP Publication 60. Results: …
Population exposure to diagnostic use of ionizing radiation in the Netherlands
MJP Brugmans, WCAM Buijs, J Geleijns… - Health …, 2002 - journals.lww.com
The use of ionizing radiation for diagnostic medical procedures and the exposure of the
Dutch population to this radiation were assessed for 1998. The annual average effective dose …
Dutch population to this radiation were assessed for 1998. The annual average effective dose …
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer
EJ Postema, PKE Börjesson, WCAM Buijs… - Journal of Nuclear …, 2003 - Soc Nuclear Med
From December 1999 until July 2001, a phase I dose escalation study was performed with
186 Re-labeled bivatuzumab, a humanized monoclonal antibody against CD44v6, on …
186 Re-labeled bivatuzumab, a humanized monoclonal antibody against CD44v6, on …
Radioimmunotherapy with [131I]cG250 in Patients with Metastasized Renal Cell Cancer: Dosimetric Analysis and Immunologic Response
AH Brouwers, WCAM Buijs, PFA Mulders… - Clinical cancer …, 2005 - AACR
Purpose: A study was designed to define the therapeutic efficacy, safety, and toxicity of two
sequential high-dose treatments of radioimmunotherapy with [ 131 I]cG250 in patients with …
sequential high-dose treatments of radioimmunotherapy with [ 131 I]cG250 in patients with …